Clomazone

Clomazone

SCHEMBL6280248

CC1(C)CON(Cc2ccccc2Cl)C1=O.CC1(C)CON(Cc2ccccc2Cl)C1=O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.53
ALDH1A1 P00352 3/20 0.44
HTT P42858 2/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 1/20 0.42
CYP2A13 Q16696 2/20 0.42
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 2/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clomazone SCHEMBL29355790 1.00 BRD4 (0.53) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL23519 1.00 BRD4 (0.53) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL29007626 0.99 BRD4 (0.52) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL28933179 0.99 BRD4 (0.52) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL21816605 0.99 BRD4 (0.52) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL28942204 0.99 BRD4 (0.52) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL20723900 0.99 BRD4 (0.52) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL21816622 0.97 BRD4 (0.51) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL28461870 0.95 BRD4 (0.49) BRD4ALDH1A1HTTATMSMN1; SMN2
Clomazone SCHEMBL28430232 0.93 BRD4 (0.48) BRD4ALDH1A1HTTATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1136515-B1 Siloxane-containing oil compositions with good spreading properties GOLDSCHMIDT GMBH (DE) 2005-12-14 EP disclosed
US-20050142113-A1 Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components MCLEOD RIMA I (US) 2005-06-30 US disclosed
US-6734141-B2 COMPRISES SILANOL-ENDCAPPED POLYETHERS FOR INCREASING RAIN-FASTNESS; HUMECTANT-FREE GOLDSCHMIDT AG (DE) 2004-05-11 US disclosed
US-20030104944-A1 Use of non-spreading silicone surfactants in agrochemical compositions EVONIK DEGUSSA GMBH (DE) 2003-06-05 US disclosed
EP-1314356-A1 Use of non-spreading silicone surfactants in agrochemical compositions Goldschmidt AG (DE) 2003-05-28 EP disclosed
EP-1150709-A2 ANTI-MICROBIAL AGENTS, DIAGNOSTIC REAGENTS, AND VACCINES BASED ON APICOMPLEXAN PARASITE COMPONENTS Mcleod, Rima W. (US) 2001-11-07 EP disclosed
EP-1136515-A2 Siloxane-containing oil compositions with good spreading properties Goldschmidt AG (DE) 2001-09-26 EP disclosed
WO-2000066154-A2 ANTI-MICROBIAL AGENTS, DIAGNOSTIC REAGENTS, AND VACCINES BASED ON UNIQUE APICOMPLEXAN PARASITE COMPONENTS ARCH DEVELOPMENT CORPORATION (US) 2000-11-09 WO disclosed
EP-0918868-A2 ANTIMICROBIAL AGENTS, DIAGNOSTIC REAGENTS, AND VACCINES BASED ON UNIQUE APICOMPLEXAN PARASITE COMPONENTS ARCH DEVELOPMENT CORPORATION (US) 1999-06-02 EP disclosed
EP-0574418-B1 ARYL SULPHONYL UREA COMPOUNDS, A METHOD OF PREPARING THEM, AND THEIR USE AS HERBICIDES AND GROWTH REGULATORS HOECHST SCHERING AGREVO GMBH (DE) 1998-11-11 EP disclosed
WO-1998003661-A9 ANTIMICROBIAL AGENTS, DIAGNOSTIC REAGENTS, AND VACCINES BASED ON UNIQUE APICOMPLEXAN PARASITE COMPONENTS 1998-05-28 WO disclosed
WO-1998003661-A2 ANTIMICROBIAL AGENTS, DIAGNOSTIC REAGENTS, AND VACCINES BASED ON UNIQUE APICOMPLEXAN PARASITE COMPONENTS ARCH DEVELOPMENT CORPORATION (US) 1998-01-29 WO disclosed
US-5688745-A Arylsulfonylureas and their use as herbicides and growth regulators HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-18 US disclosed
US-5463081-A Chemical intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-31 US disclosed
EP-0574418-A1 ARYL SULPHONYL UREA COMPOUNDS, A METHOD OF PREPARING THEM, AND THEIR USE AS HERBICIDES AND GROWTH REGULATORS Hoechst Schering AgrEvo GmbH (DE) 1993-12-22 EP disclosed
WO-1992020684-A1 HERBICIDAL OXATRICYCLIC ETHERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-11-26 WO disclosed
WO-1992013861-A1 HERBICIDAL BICYCLIC ETHERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-08-20 WO disclosed
WO-1992013845-A1 ARYL SULPHONYL UREA COMPOUNDS, A METHOD OF PREPARING THEM, AND THEIR USE AS HERBICIDES AND GROWTH REGULATORS HOECHST AKTIENGESELLSCHAFT (DE) 1992-08-20 WO disclosed
WO-1992010501-A1 HERBICIDAL ETHERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-06-25 WO disclosed
WO-1992009578-A1 SUBSTITUTED FUSED HETEROCYCLIC HERBICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050142113-A1 Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components POLRMT, PCK1, PSAT1 BRD4 3702/4885ALDH1A1 4756/4885HTT 3169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.